Randolf Brehler Selected Research

Randolf Brehler Research Topics

Disease

16	Hypersensitivity (Allergy) 09/2023 - 01/2002
7	COVID-19 11/2022 - 01/2020
6	Chronic Urticaria 08/2023 - 07/2011
5	Asthma (Bronchial Asthma) 09/2023 - 09/2008
5	Anaphylaxis (Anaphylactic Shock) 01/2023 - 08/2013
4	Urticaria (Hives) 10/2019 - 07/2011
3	Eczema 01/2023 - 01/2022
3	Allergic Rhinitis 01/2023 - 09/2008
2	Bites and Stings (Sting) 01/2023 - 08/2013
2	Contact Dermatitis (Eczema, Contact) 01/2022 - 01/2020
2	Syphilis 04/2021 - 01/2021
2	Venom Hypersensitivity 01/2020 - 08/2013
2	Pruritus (Itching) 10/2011 - 07/2011
1	Atopic Dermatitis (Atopic Eczema) 09/2023
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2023
1	Mastocytosis 01/2023
1	Immediate Hypersensitivity 11/2022
1	Allergic Contact Dermatitis 01/2022
1	Peanut Hypersensitivity (Peanut Allergy) 01/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Inflammation (Inflammations) 01/2021
1	Drug Hypersensitivity (Drug Allergy) 01/2020
1	Solar Urticaria 01/2018
1	Chronic Inducible Urticaria 01/2018
1	Cold Urticaria 01/2018
1	Angioedema 01/2018
1	Familial dermographism 01/2018
1	Rhinitis 09/2016
1	Insect Bites and Stings (Insect Bite) 08/2013
1	Food Hypersensitivity (Food Allergy) 03/2011
1	Rhinosinusitis 01/2008
1	Spinal Dysraphism (Spina Bifida) 01/2002

Drug/Important Bio-Agent (IBA)

8	AllergensIBA 09/2023 - 01/2003
7	Omalizumab (Xolair)FDA Link 01/2023 - 01/2008
6	anti-IgE antibodiesIBA 01/2023 - 01/2008
6	Immunoglobulin E (IgE)IBA 01/2017 - 01/2002
5	Arthropod VenomsIBA 01/2023 - 01/2011
5	VaccinesIBA 11/2022 - 01/2021
4	AntibodiesIBA 01/2017 - 03/2011
3	Penicillins (Penicillin)FDA Link 04/2021 - 01/2020
3	CarbohydratesIBA 08/2013 - 01/2011
2	VenomsIBA 01/2023 - 01/2011
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2023 - 01/2021
2	Bee Venoms (Bee Venom)IBA 01/2023 - 01/2011
2	Messenger RNA (mRNA)IBA 11/2022 - 01/2021
2	COVID-19 VaccinesIBA 11/2022 - 01/2021
2	LactaseIBA 09/2016 - 10/2011
1	Air Pollutants (Pollutants, Air)IBA 09/2023
1	Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA 08/2023
1	rupatadineIBA 08/2023
1	Tryptases (Tryptase)IBA 01/2023
1	mRNA VaccinesIBA 11/2022
1	Irritants (Vesicants)IBA 01/2022
1	BNT162 VaccineIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	beta Lactam AntibioticsIBA 01/2020
1	beta-LactamsIBA 01/2020
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 10/2019
1	ligelizumabIBA 10/2019
1	Cholinergic Agents (Cholinergics)IBA 01/2018
1	Local Anti-Infective Agents (Antiseptics)IBA 01/2017
1	ChlorhexidineIBA 01/2017
1	BiguanidesIBA 01/2017
1	polihexanideIBA 01/2017
1	TabletsIBA 09/2016
1	Dapsone FDA Link 11/2011
1	Lactose FDA LinkGeneric 10/2011
1	AutoantigensIBA 07/2011
1	Histamine Antagonists (Antihistamines)IBA 07/2011
1	AutoantibodiesIBA 07/2011
1	Polysaccharides (Glycans)IBA 03/2011
1	Peptides (Polypeptides)IBA 03/2011
1	Xylose (D-Xylose)FDA Link 03/2011
1	FucoseIBA 03/2011
1	Glycoproteins (Glycoprotein)IBA 03/2011
1	Rubber (Elastica)IBA 01/2002

Therapy/Procedure

13	Therapeutics 01/2023 - 07/2011
4	Immunotherapy 01/2020 - 09/2008
1	Off-Label Use 01/2023
1	Emergency Treatment 01/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Injections 05/2010